Skip to main content

The Polygenic Risk Methods in Diverse Populations (PRIMED) Consortium (comprised of NIH program staff, affiliate members, investigators at 7 study sites, and a Coordinating Center) is funded by the National Institutes of Health to develop and evaluate methods improve the predictive capacity of polygenic risk scores for populations of diverse ancestry. ELSI activities in PRIMED are expected to explore the implications of integrating heterogeneous datasets and generating PRS data which may differentially impact individuals of diverse ancestry. This will include considerations of how to conceptualize and use ancestry and other population descriptors in PRS methods development and applications.

Keywords
Polygenic risk scores
precision medicine
diversity
Genetic Risk
multi-site